Table 1 all of the lncRNAs associated with cell cycle regulation in BCa
LncRNA | Target | Samples | Year | Refs. |
|---|---|---|---|---|
TUG1 | CCND1 and CDK4 | 58 NT MDA-MB-231, MDA-MB-453, MDA- MB-468, T-47D, MCF-7, ZR-75, and SK-BR-3, and MCF-10A cell lines | 2017 | Fan [38] |
LINC01355 | CCND1 and FOXO3 | 48 NT MCF-7, MDA-MB-231 cell lines | 2019 | Ai [42] |
CASC9 | miR‑195/497 | 17 NT MCF-10A, MDA-MB-231, MDA-MB-468, MCF7, and MDA-MB-415 cell lines | 2019 | Shao [43] |
FOXC2-AS1 | CCND1, Cyclin D2, and Cyclin D3 | 56 NT MCF-10A and BC cell lines MDA-MB-468, MDA-MB-231, MDA- MB-436, and MCF-7 cell lines | 2019 | Yang [44] |
AP000439.3 | CCND1 | MCF7, ZR-75-1, and T47D cell lines | 2017 | Zhang [48] |
MAFG-AS1 | miR-339-5p | 50 NT MCF-7, BT474, T47D, MCF-10A, MDA- MB-231 and MDA-MB-468 cell lines | 2020 | Feng [49] |
CCAT2 | CCND1, Cyclin E1, CDK4, p15, and EZH2 | 120 NT MCF-7, MDA-MB-231, and MCF10A cell lines | 2017 | Deng [50] |
ITGB1 | Cdc25C, Cyclin B1, and E-cadherin | 20 NT* MDA-MB-231, MCF-7, T47D, ZR-75-30, and 1590, and HBL-100 cell lines | 2017 | Yan [56] |
PRNCR1-2 | pCHK2 and pAKT | HS-578 T, and MDA-MB-231 cell lines | 2019 | Pang [61] |
Lnc712 | HSP90, Cdc37, and CDK2 | MCF-10A, MDA-MB-231, MCF-7, and MCF-7/ADM cell lines | 2020 | Cui [63] |
DSCAM‐AS1 | miR‐137 | 30 NT MCF7, T47D, SK‐BR‐3, and MDA‐MB‐31 cell lines | 2019 | Ma [64] |
SNHG1 | miR‑573 | 50 NT MCF10A, MCF7, T47D, MDA-MB-231, and MDA-MB-468 cell lines | 2020 | Xiong [69] |
HOST2 | Let-7b | 30 NT MDA-MB-231, and MDA-MB-468 cell line | 2019 | Zhang [70] |
ASncmtRNA | Cyclin B1, CCND1, CDK1, and CDK4 | MDA-MB-231, MCF7, and ZR-75-1 (CRL-1500) cell lines | 2019 | Fitzpatrick [77] |
LINC01089 | CDK4 and CDK6 | 63 NT MDA-MB-231, BT- 549, SUM-159, MDA-MB-468, SK-BR-3, MCF-7, YCCB1,T47D, and MCF-10A cell lines | 2019 | Yuan [83] |
LINC00668 | CDK4, Bcl-2, p21, AKT, and mTOR | T47D, MCF7, MDA-MB-231, MDA- MB-436, and MCF-10A cell lines | 2019 | Qiu [88] |
PTENP1 | Cyclin A2 and CDK2 | MCF7, and 293 T cell lines | 2017 | Chen [92] |
GHET1 | EGFR, c-Myc, PI3K, AKT, Cyclin D1, MMP-2, and MMP-9 | 30 NT MCF-7 cell line | 2019 | Han [93] |
MIR100HG | p27 | MDA-MB-231 and BT549 cell lines | 2018 | Wang [98] |
LINC00993 | p16INK4A, p14ARF, p53, and p21 | MDA-MB-231 and BT-549 cell lines | 2019 | Guo [99] |
LincIN | p21 | MCF- 10A and -10F, BT- 20, HCC-1937, MCF-7, MDA-MB-231, SK-BR-3, T-47D, ZR-75-1, MDA-MB-231luc, MCF10ADCIS, and SUM225 cell lines | 2017 | Jiang [100] |
RP1 | p27 | HEK-293 T, MCF-7, T47D, SKBR3, MDA-MB-231, BT549, HCC38, HCC1937, and MCF-10A cell lines | 2019 | Jia [101] |
MIAT | miR-302, miR-150, and miR-29c | 31 NT NCCIT, MCF7, SKBR-3, PC-3, LNCaP, A-172, U-87, SH-SY5Y, HT-29, SW48, SW480, SW1116, AGS, HELA, Hep G2, MDA-MB-231, and DPSC cell lines | 2018 | Alipoor [106] |
RUSC1-AS1 | KLF2 and CDKN1A | 48 NT MDA-MB-231, MCF-7, BT549, and MCF-10A cell lines | 2019 | Hu [110] |
PVT1 | miR-1207-5p | 50 NT T-47D, MDA-MB-231, BT-474,MCF-7, SKBR3, and 293 T, T- 47D, MDA-MB-231, BT-474, and MCF-10A cell lines | 2017 | Yan [115] |
MALAT1 | miR-124 | MCF-7, Bcap-37 and MDAMB-435S, HCC1937, ZR-75-1, HS578T, and MDA-MB-231 cell lines | 2016 | Feng [118] |
ERINA | E2F1 and RB1 | MCF10A, BT-20, HCC1937, HS578T, MDA-MB-MB231, ZR-75-1, BT-474, MDA-MB-231, MCF7, T47D, and 293 T cell lines | 2020 | Fang [119] |
H19 | E2F6 and E2F1 | MCF-7, T47D, BT20, and MDA-MB-231 cell lines | 2005 | Berteaux [120] |
Lnc-CDC6 | CDC6 and miR‐215 | 105 normal and 837 breast cancer tissues MCF‐10A, MCF‐10AT, MCF‐10CA1A, and MCF‐10CA1H, MDA‐MB‐231, MDA‐MB‐468, MCF‐7, MDA‐MB‐453, ZR‐75‐1, Hs578T, T47D, and SK‐BR‐3 cell lines | 2019 | Kong [124] |
PANDAR | Bmi1 and p16 | BT474, SK-BR3, MCF-7, T47D, and MDA-MB-231 cell lines | 2016 | Sang [127] |
UCA1 | EZH2, p21, PI3K, and AKT | 10 NT MCF-7, T47D, LCC2, and LCC9 cell lines | 2019 | Li [136] |